TinyGemsBreaks Archive - Page 71 of 125

ThursdayApr 27, 2023 11:26 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate, Present at Upcoming Virtual Investor Spotlight Event

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at an upcoming Virtual Investor Spotlight Event. The event is titled Virtual Investor Spotlight Event - Rapidly Advancing GBM Pivotal Study. According to the announcement, the live, moderated video webcast is scheduled to begin at noon on May 3, 2023, and will feature members of CNS Pharmaceuticals management, including CEO John Climaco; chief medical officer Sandra Silberman, MD, PhD; and VP of clinical operations Zena Muzyczenko. These key executives will discuss the progress…

WednesdayApr 26, 2023 3:39 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Site of Upcoming Robot Roadshow, Deploys ASR to Bay-Area Biotech

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced the site of its May 9–11, 2023, Robot Roadshow “landing.” Jena Choctaw Pines Casino, located in Dry Prong, Louisiana, will host the three-day in-person event, designed to be an experiential event to grab attention; forge direct connections with potential clients, investors and the media; and strike up conversations about KSCP’s exciting technologies. The Louisiana stop will be the 80thlanding in 25 states. During the roadshow, Knightscope experts demonstrate available products and services in a climate-controlled, space-age “pod” that allow those participating to…

TuesdayApr 25, 2023 12:45 pm

TinyGemsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Fr8App Named BeatBox’s No. 1 Carrier for Cross Border Shipments

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning, offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today announced that its Fr8App was named BeatBox Beverages’ number one carrier for cross-border shipments. “At Fr8Tech, we are committed to providing our clients with the best possible service and solutions for their shipping needs. Our business relationship with BeatBox Beverages is a testament to the power of our technology and the expertise of our team,” said Javier Selgas, CEO of Fr8Tech.…

TuesdayApr 25, 2023 10:35 am

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced that it has closed on its previously announced registered direct offering. The company transacted the closing with a single healthcare-focused institutional investor; the closing consisted of the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof), which were made available at a purchase price of $1.22 per share. In addition, the company also transacted a concurrent private placement, which included the issuance of unregistered warrants to purchase up to 3,170,700 shares of common stock;…

MondayApr 24, 2023 1:28 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards CRO Contract for Upcoming Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it awarded the contract for clinical research organization (“CRO”) services to California-based InClin, Inc. for its expected upcoming Food and Drug Administration (“FDA”)-registered, U.S. phase 1b Investigational New Drug (“IND”) hypertension study HYPER-H23-1 with its patented DehydraTECH-powered cannabidiol (“DehydraTECH-CBD”). According to the announcement, HYPER-H23-1 is entitled “A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of DehydraTECH-CBD in Subjects with Stage 1 or Stage 2 Hypertension.” The study’s primary objective will be to evaluate safety and tolerability in 120 hypertensive patients,…

MondayApr 24, 2023 11:44 am

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q1 2023 Earnings Results, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that it will provide a business update and release its financial results for the first quarter of 2023 following the close of the market on Tuesday, May 9, 2023. At 2:30 p.m. PT on that same day, Cepton will hold a conference call and webcast. Interested parties should dial 1-888-886-7786 (toll-free) or 1-416-764-8658 (international) to join the live call and visit https://ibn.fm/dsycf to access the live webcast. A telephonic replay of the conference call will be available as detailed in the announcement. To view the…

MondayApr 24, 2023 11:20 am

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) MAEO to Execute $680K Contract with the District of Columbia

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its majority owned subsidiary, Mullen Advanced Energy Operations (“MAEO”), will today begin execution of a $680,000 contract that was previously awarded by the District of Columbia, Washington, D.C., to EV Technologies, LLC. The contract covers the purchase and installation of Energy Management Module (“EMM”) units on Chevrolet Bolts within the D.C. city government’s vehicle fleet. “The D.C. city project is the first of many that we have planned for the new EMM technology,” said David Michery, CEO and chairman of Mullen Automotive. “Municipal city fleets are a…

FridayApr 21, 2023 1:46 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently reported the enrollment of the first patient in Switzerland as a participant in its ongoing potentially pivotal global trial evaluating Berubicin for the treatment of glioblastoma multiforme (“GBM”). “CNS Pharmaceutical’s adaptive, multicenter, open-label, randomized controlled study targets adult patients with recurrent GBM after failure of standard first-line therapy. In addition, the study will also enroll patients who have received additional treatments as part of the first-line therapy in recognition of the complexity of new agents introduced as a component of this therapy. The study will compare Berubicin, a novel anthracycline and the first anthracycline to…

FridayApr 21, 2023 12:45 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Differentiated with Focus on Tech-Driven Solutions, Outstanding Customer Service

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) recently acknowledged an endorsement by leading investment and research firm Chardan Capital Research that included a buy rating for the company at a price target of $2.00. “We are pleased to be able to share the results of Chardan’s independent analysis of our company’s growth and potential. Our focus on technology-driven solutions and outstanding customer service has allowed us to differentiate ourselves in the market, and we will continue to build on that success,” a recent article quotes Fr8Tech CEO Javier Selgas as saying. “Fr8Tech has built a suite of technology-based solutions to help automate…

FridayApr 21, 2023 9:40 am

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has entered into a definitive agreement. The company announced a registered direct offering totaling $1.9 million; the agreement is with a single healthcare-focused institutional investor and includes the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.22 per share (or common stock equivalents in lieu thereof). According to the announcement, a concurrent private placement calls for the company to also issue unregistered warrants to purchase up to 3,170,700…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks